Life Science REIT PLC
LSE:LABS
Net Margin
Life Science REIT PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
UK |
L
|
Life Science REIT PLC
LSE:LABS
|
132.3m GBP |
-69%
|
|
US |
![]() |
Welltower Inc
NYSE:WELL
|
108B USD |
12%
|
|
US |
![]() |
Ventas Inc
NYSE:VTR
|
30.5B USD |
4%
|
|
US |
![]() |
Omega Healthcare Investors Inc
NYSE:OHI
|
11.9B USD |
41%
|
|
US |
![]() |
Physicians Realty Trust
NYSE:DOC
|
11.9B USD |
6%
|
|
US |
H
|
Healthpeak Properties Inc
F:HC5
|
10.1B EUR |
6%
|
|
US |
C
|
CareTrust REIT Inc
NYSE:CTRE
|
6.7B USD |
59%
|
|
US |
H
|
Healthcare Trust Of America Inc
F:HT01
|
5.3B EUR |
12%
|
|
US |
![]() |
Healthcare Realty Trust Inc
NYSE:HR
|
5.8B USD |
-33%
|
|
US |
![]() |
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
4.5B USD |
25%
|
|
BE |
![]() |
Aedifica NV
XBRU:AED
|
3.1B EUR |
50%
|
Life Science REIT PLC
Glance View
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Life Science REIT PLC's most recent financial statements, the company has Net Margin of -68.8%.